Did You Know...
...that Kleenex tissue was originally designed to be a gas mask filter? It was developed at the beginning of World War I to replace cotton, which was then in short supply as a surgical dressing.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20130103139 | COATING OF ENDOPROSTHESES WITH A COATING CONSISTING OF A TIGHT MESH OF POLYMER FIBERS The present invention relates to grid-like or net-like endoprosthesis having a continuous, respectively ongoing and interstices-spanning coating with a thread-tangle, wherein this continuous, respectively ongoing and interstices-spanning coating covers the struts as wel... | 04/25/2013 |
| 20130103138 | SURFACE MODIFICATION OF MEDICAL DEVICES TO ENHANCE ENDOTHELIAL ADHESION AND COVERAGE Acceleration of the endothelialization process on implantable medical devices having at least one blood-contacting surface is achieved by a microscale pattern of sub-sections of EC-inductive coatings or EC-conductive coatings and nano/macro textured surfaces. The EC-ind... | 04/25/2013 |
| 20130085565 | ELECTROSPUN PTFE COATED STENT AND METHOD OF USE A stent or other prosthesis may be formed by coating a single continuous wire scaffold with a polymer coating. The polymer coating may consist of layers of electrospun polytetrafluoroethylene (PTFE). Electrospun PTFE of certain porosities may permit endothelial cell gro... | 04/04/2013 |
| 20130046375 | PLASMA MODIFIED MEDICAL DEVICES AND METHODS Coatings, devices and methods are provided, wherein the contacting surface of a medical device with at least one contacting surface for contacting a bodily fluid or tissue, wherein long-lasting and durable bioactive agents or functional groups are deposited on the conta... | 02/21/2013 |
| 20130035756 | VASCULAR STENT HAVING A DUAL COATING STRUCTURE Disclosed is a vascular stent which is inserted inside a blood vessel. The disclosed vascular stent includes: a first coating film comprising a restenosis inhibiting drug provided on the outside surface of the stent strut; and a second coating film comprising an interna... | 02/07/2013 |
| 20120310329 | SUSTAINED DRUG-RELEASING STENT A stent includes a stent body of a cylindrical configuration having outer and inner surfaces, a first coated layer coating at least the outer surface, and a second coated layer coating substantially completely over the first coated layer. The first coated layer is prepa... | 12/06/2012 |
| 20120245677 | BIORESORBABLE NITRIC OXIDE AGONIST PRODRUG SCAFFOLDS FOR VASCULAR STENTS The present invention relates to a bioresorbable scaffold for a vascular stent comprising a nitric oxide agonist and a polymer comprising a lactide, a glycolide and a lactone. The nitric oxide agonist is a statin or a HMG CoA reductase inhibitor. The nitric oxide agonis... | 09/27/2012 |
| 20120239139 | MEDICAL IMPLANTS CONTAINING FK506 (TACROLIMUS) METHODS OF MAKING AND METHODS OF USE THEREOF Implants and methods of making same are provided for treatment or prophylaxis of coronary or peripheral vascular constrictions or vascular occlusions, and particularly, stenoses or restenoses, that comprise FK506 in chemically covalently bound, non-covalently bound or p... | 09/20/2012 |
| 20120239140 | MEDICAL PRODUCT COMPRISING AN ACTIVE COATING An embodiment of the present invention relates to a medical product coated with a polymer layer, which comprises an inhibitor of the TRPC-3 ion channel underneath, in, and/or on the biostable or biodegradable polymer layer.... | 09/20/2012 |
| 20120197387 | STENT WITH INTERNAL FORCE AND FABRICATION METHOD THEREOF A stent includes: a main body unit including a plurality of through holes and configured to have a net-like shape; and a coating unit filling the through holes of the main body unit and configured as a layer on the main body unit, wherein the main body unit has force of... | 08/02/2012 |
| 20120185037 | GROOVED DRUG-ELUTING MEDICAL DEVICES AND METHOD OF MAKING SAME The invention relates to methods and apparatus for manufacturing implantable medical devices, such as intravascular stents, wherein the medical device has a surface treated to promote the migration of endothelial cells onto the surface of the medical device. In particul... | 07/19/2012 |
| 20120171260 | Stent And Delivery System With Reduced Chemical Degradation Stents and delivery systems with reduced chemical degradation and methods of sterilizing the same are disclosed.... | 07/05/2012 |
| 20120172976 | Methods and Devices for Delivering Therapeutic Agents to Target Vessels The present disclosure pertains to stents having a coating applied thereto, wherein the coating comprises a biocompatible polymer/drug mixture, as well as devices comprising a metallic stent, a biocompatible polymeric carrier and a drug.... | 07/05/2012 |
| 20120158127 | BIOABSORBABLE AND BIOCOMPATIBLE POLYURETHANES AND POLYAMIDES FOR MEDICAL DEVICES Absorbable polyurethanes, polyamides and polyester urethanes prepared from at least one compound selected from: or the corresponding diamines or diisocyanates thereof, wherein each X independently represents ... | 06/21/2012 |
| 20120150281 | IMPLANT MADE OF BIOCORRODIBLE MATERIAL AND WITH A COATING CONTAINING A TISSUE ADHESIVE The invention relates to an implant having a base body made of a biocorrodible material. A surface of the implant has a coating at least in some regions, wherein the coating comprises a tissue adhesive.... | 06/14/2012 |
| 20120150285 | MEDICAL DEVICES CONTAINING DRY SPUN NON-WOVENS OF POLY-4-HYDROXYBUTYRATE AND COPOLYMERS Continuous processing methods for making absorbable polymeric dry spun non-wovens with one or more of the following properties: high burst strength, fine fibers of average diameter from 0.01 μm to 50 μm, and thickness from 10 μm to 10 mm, have been developed. Improve... | 06/14/2012 |
| 20120150286 | BIOERODIBLE ENDOPROSTHESIS WITH BIOSTABLE INORGANIC LAYERS Medical devices such as endoprostheses (e.g., stents) containing one or more biostable layers (e.g., biostable inorganic layers) and a biodegradable underlying structure are disclosed.... | 06/14/2012 |
| 20120150277 | CONTINUOUS DOUBLE LAYERED STENT FOR MIGRATION RESISTANCE The present invention relates to stent structures having improved migration resistance. In particular, the invention relates to mesh stents, such as braided or twisted stent designs, where at least a portion of the stent is folded back over itself to form a multi-layere... | 06/14/2012 |
| 20120143318 | IMPLANT MADE OF A METALLIC MATERIAL WHICH CAN BE RESORBED BY THE BODY The invention relates to an implant consisting of a metallic magnesium alloy that can be resorbed by the body, said metallic material being a magnesium alloy consisting of at least 96% w/w of magnesium, at least 1% w/w of manganese and at least 0.5% w/w of at least one ... | 06/07/2012 |
| 20120130482 | VASCULAR STENTS The disclosure describes a coating for medical implants, in particular, vascular stents, said coating comprising silicon dioxide, towards medical implants with a coating containing silicon dioxide and towards a method for their production. The coating can contain additi... | 05/24/2012 |
| 20120130483 | TUBULAR IMPLANT FOR REPLACING NATURAL BLOOD VESSELS A tubular implant that replaces natural blood vessels includes a prefabricated vascular prosthesis with an internal surface, an external surface and a wall, wherein the internal and/or external surface of the prefabricated vascular prosthesis has a polyurethane coating.... | 05/24/2012 |
| 20120121658 | FUNCTIONALIZED RGD PEPTIDOMIMETICS AND THEIR MANUFACTURE, AND IMPLANT HAVING A COATING CONTAINING SUCH FUNCTIONALIZED RGD PEPTIDOMIMETICS At least some embodiments of the invention relates to an implant having a coating that contains or is composed of a functionalized RGD peptidomimetic RGD-P1 having the formula (1) and/or a functionalized RGD peptidomimetic RGD-P2 having the formula (2), and an associate... | 05/17/2012 |
| 20120123514 | METHOD AND DEVICE FOR TREATMENT OF ARRHYTHMIAS AND OTHER MALADIES Devices and methods are described for treating maladies such as atrial fibrillation. The devices and methods, in some implementations, include two rings separated by a helical winding. The rings and at least one helical winding provide mechanical pressure against an adj... | 05/17/2012 |
| 20120116502 | SURFACE TEXTURED IMPLANTS Devices and methods for controlling the flaking of coating fragments from medical implants and improving the delivery of therapeutic agents from such coatings are described.... | 05/10/2012 |
| 20120116503 | COATED MEDICAL DEVICES AND METHODS The invention relates to medical device systems that include a delivery instrument comprising a sheath having an abluminal surface and a luminal surface; a radially-expandable frame disposed at least partially within the sheath, the frame having an abluminal surface at ... | 05/10/2012 |
| 20120109285 | METHOD FOR MASS TRANSER OF MICRO-PATTERNS ONTO MEDICAL DEVICES This invention is directed to a new method of mass-transfer/fabrication of micro-sized features/structures onto the inner diameter (ID) surface of a stent. This new approach is provided by technique of through mask electrical micro-machining. One embodiment discloses an... | 05/03/2012 |
| 20120109286 | ANTIMICROBIAL COATINGS The present invention relates to methods for forming antimicrobial coatings, and to compounds suitable for forming the antimicrobial coatings, and to substrates coated with the antimicrobial coatings. The coatings are formed by vapour phase plasma polymerisation of meta... | 05/03/2012 |
| 20120109287 | METHOD OF ELECTROPLATING A CONVERSION ELECTRON EMITTING SOURCE ON IMPLANT Methods for preparing an implant coated with a conversion electron emitting source (CEES) are disclosed. The typical method includes cleaning the surface of the implant; placing the implant in an activating solution comprising hydrochloric acid to activate the surface; ... | 05/03/2012 |
| 20120109283 | STENT HAVING ADJACENT ELEMENTS CONNECTED BY FLEXIBLE WEBS A stent incorporating flexible, preferably polymeric, connecting elements into the stent wherein these elements connect adjacent, spaced-apart stent elements. Preferably the spaced-apart adjacent stent elements are the result of forming the stent from a helically wound ... | 05/03/2012 |
| 20120093944 | Method for surface inclusions detection, enhancement of endothelial and osteoblast cells adhesion and proliferation, sterilization of electropolished and magnetoelectropolished nitinol surfaces The method for surface inclusions detection, enhancement of endothelial and osteoblast cells adhesion and proliferation and sterilization of electropolished and magnetoelectropolished Nitinol implantable medical device surfaces uses an aqueous solution of chemical compo... | 04/19/2012 |
| 20120095541 | Stent for Temporary Fitting in a Body Cavity A stent for positioning in a body lumen having a cylindrical shape extending along a longitudinal axis surrounded by a stent wall which defines a diameter of an axial passage communicating with openings on two opposite ends of the stent. The wall is configured so as to ... | 04/19/2012 |
| 20120095548 | MEDICAL IMPLANT INCLUDING A MAGNESIUM-BASED TIE LAYER A medical implant includes a metallic base, a tie layer, and at least a first layer overlying an outer surface of the tie layer. The tie layer is bonded to at least a portion of a surface of the metallic base. The tie layer includes magnesium or a magnesium-based alloy.... | 04/19/2012 |
| 20120095542 | INTRALUMINAL MEDICAL DEVICE A multi-sided intraluminal medical device having a self-expanding frame and a pair of guide bars located on opposite ends of the frame and adapted to enable the frame to be retracted for delivery or retrieval from either end is provided. The intraluminal device may furt... | 04/19/2012 |
| 20120078349 | COATED IMPLANT COMPOSED OF A BIOCORRODIBLE MAGNESIUM ALLOY One embodiment of the invention relates to a coated implant having a base body composed of a biocorrodible magnesium alloy. The coating of the implant comprises: (i) a base layer, which is applied to the base body, composed of a basic polym... | 03/29/2012 |
| 20120071962 | INTRAVASCULAR STENT Stents are provided with scaffold structures which have low exposures when implanted in arteries and other blood vessels and lumens. The cross-sectional dimensions, materials, and patterns are controlled to provide sufficient strength and coverage while maintaining the ... | 03/22/2012 |
| 20120071967 | ONE-STEP PHOSPHORYLCHOLINE-LINKED POLYMER COATING AND DRUG LOADING OF STENT A one step method for drug coating an interventional device is disclosed by mixing a drug with a phosphorylcholine-linked methacrylate polymer in a liquid and applying the mixture to an interventional device, such as a stent, in a single step.... | 03/22/2012 |
| 20120065726 | BIOERODIBLE ENDOPROSTHESES AND METHODS OF MAKING THE SAME A bioerodible endoprosthesis erodes by galvanic erosion that can provide, e.g., improved endothelialization and therapeutic effects.... | 03/15/2012 |
| 20120065727 | MECHANICALLY ATTACHED MEDICAL DEVICE COATINGS The present invention relates to nanofibrous coatings on medical devices such a surgical mesh or stent, wherein the coating is mechanically attached to the device. The principal mechanism for attaching the coating is through causing the fibers to permeate and entangle w... | 03/15/2012 |
| 20120059456 | MODIFICATION OF STENT SURFACES TO IMPART FUNCTIONALITY In one aspect, the invention relates to coated substrates comprising a substrate having a surface, a cationic polymer layer adjacent the surface of the substrate, an anionic polymer layer adjacent the cationic polymer layer and methods for producing and using same. In o... | 03/08/2012 |
| 20120059455 | Bioerodible Magnesium Alloy Containing Endoprostheses A bioerodible endoprosthesis includes a bioerodible magnesium alloy. The bioerodible magnesium alloy includes magnesium, between 7 and 8 weight percent aluminum, between 0.4 and 0.8 weight percent zinc, and between 0.05 and 0.8 weight percent manganese.... | 03/08/2012 |
